Literature DB >> 3016501

Differences in the mechanism of functional interaction between NADPH-cytochrome P-450 reductase and its redox partners.

P P Tamburini, J B Schenkman.   

Abstract

Selective methylamidation of NADPH-cytochrome P-450 reductase (EC 1.6.2.4) carboxyl groups was used to assess the relative importance of these groups in the enzyme-catalyzed reduction of cytochromes c, b5, and P-450. Methylamidation of as few as 7 mol of carboxyl groups per mol of reductase caused 80% inhibition of cytochrome c reduction, 50% inhibition of rat liver microsomal RLM3 reduction, and up to 90% inhibition in the capacity of the reductase to support reconstituted monooxygenase activities of RLM3, RLM5, and LM2. In marked contrast, cytochrome b5 reduction measured under comparable conditions was stimulated by 50%. The impaired interactions between the reductase and cytochromes P-450 LM2 and RLM5 were shown not to arise from an impaired capacity for the proteins to bind each other but more likely to be due to an inhibition of a step(s) subsequent to complex formation between the oxidized proteins. These results show that the reductase interacts functionally with cytochrome c and cytochromes P-450 on the one hand and cytochrome b5 on the other through different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016501

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution.

Authors:  Q Zhao; S Modi; G Smith; M Paine; P D McDonagh; C R Wolf; D Tew; L Y Lian; G C Roberts; H P Driessen
Journal:  Protein Sci       Date:  1999-02       Impact factor: 6.725

2.  Purification and properties of a shortened form of cytochrome P-450 2E1: deletion of the NH2-terminal membrane-insertion signal peptide does not alter the catalytic activities.

Authors:  J R Larson; M J Coon; T D Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

3.  Defensive nature of Sargassum polycystum (Brown alga) against acetaminophen-induced toxic hepatitis in rats: role of drug metabolizing microsomal enzyme system, tumor necrosis factor-alpha and fate of liver cell structural integrity.

Authors:  H Balaji Raghavendran; A Sathivel; T Devaki
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase.

Authors:  Y Omata; R Dai; S V Smith; R C Robinson; F K Friedman
Journal:  J Protein Chem       Date:  2000-01

5.  Kinetic and structural characterization of the interaction between the FMN binding domain of cytochrome P450 reductase and cytochrome c.

Authors:  Rui Huang; Meng Zhang; Freeborn Rwere; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2014-12-15       Impact factor: 5.157

6.  Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.

Authors:  Djemel Hamdane; Chuanwu Xia; Sang-Choul Im; Haoming Zhang; Jung-Ja P Kim; Lucy Waskell
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

7.  Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation.

Authors:  James R Reed; Marilyn Eyer; Wayne L Backes
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

8.  The Hinge Segment of Human NADPH-Cytochrome P450 Reductase in Conformational Switching: The Critical Role of Ionic Strength.

Authors:  Diana Campelo; Thomas Lautier; Philippe Urban; Francisco Esteves; Sophie Bozonnet; Gilles Truan; Michel Kranendonk
Journal:  Front Pharmacol       Date:  2017-10-30       Impact factor: 5.810

9.  Solution structure of the cytochrome P450 reductase-cytochrome c complex determined by neutron scattering.

Authors:  Samuel L Freeman; Anne Martel; Juliette M Devos; Jaswir Basran; Emma L Raven; Gordon C K Roberts
Journal:  J Biol Chem       Date:  2018-02-23       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.